NEU neuren pharmaceuticals limited

2025 M & A Outlook, page-2

  1. 639 Posts.
    lightbulb Created with Sketch. 343
    Great summary thanks Hottod and very encouraging!
    One thing that I'd be interested in your take or anyone who may know something - the section on Evolving deal structures talks about risk mitigation by making certain payments contingent on achieving particular outcomes. This would make a lot of sense to me if I was buying but how does that manifest for a shareholder in the targeted company (like us)? I'm assuming this is more in the realms of a partnership compared to a takeover or perhaps not and it's a payment upfront with a possibility of more to come later?? It certainly sounds like another option beyond the all cash or part cash, part scrip situations discussed here. If anyone has any experience with this please pipe up, thanks!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.62
Change
0.140(0.85%)
Mkt cap ! $2.093B
Open High Low Value Volume
$16.48 $16.77 $16.28 $1.908M 115.2K

Buyers (Bids)

No. Vol. Price($)
7 225 $16.62
 

Sellers (Offers)

Price($) Vol. No.
$16.63 39 6
View Market Depth
Last trade - 13.47pm 28/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.